Skip to main content
Top
Published in: Experimental & Translational Stroke Medicine 1/2011

Open Access 01-12-2011 | Review

Vascular pathology in multiple sclerosis: mind boosting or myth busting?

Authors: Anne Waschbisch, Arndt Manzel, Ralf A Linker, De-Hyung Lee

Published in: Experimental & Translational Stroke Medicine | Issue 1/2011

Login to get access

Abstract

The investigation of central nervous system vascular changes in the pathophysiology of multiple sclerosis (MS) is a time-honored concept. Yet, recent reports on changes in venous cerebrospinal outflow, the advent of new magnetic resonance imaging techniques and the investigation of immunomodulatory properties of several vascular mediators on the molecular level have added new excitement to hypotheses centering around vascular pathology as determining factor in the pathophysiology of MS. Here we critically review the concept of chronic cerebrospinal venous insufficiency in MS patients and describe new imaging techniques including perfusion weighted imaging, susceptibility weighted imaging and diffusion weighted imaging which reveal central nervous system hypoperfusion, perivascular iron deposition and diffuse structural changes in the MS brain. On a molecular basis, vascular mediators represent interesting targets connecting vascular pathology with immunomodulation. In summary, the relation of venous changes to the pathophysiology of MS may not be as simple as initially described and it certainly seems awkward to think of the complex disease MS solely as result of a simple venous outflow obstruction. Yet, the investigation of new vascular concepts as one variable in the pathophysiology of the autoimmune attack seems very worthwhile and may add to a better understanding of this devastating disorder.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F: Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80: 392–399.PubMedCentralPubMedCrossRef Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F: Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80: 392–399.PubMedCentralPubMedCrossRef
2.
go back to reference Hojnacki D, Zamboni P, Lopez-Soriano A, Galleotti R, Menegatti E, Weinstock-Guttman B, Schirda C, Magnano C, Malagoni AM, Kennedy C, Bartolomei I, Salvi F, Zivadinov R: Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. Int Angiol 2010, 29: 127–139.PubMed Hojnacki D, Zamboni P, Lopez-Soriano A, Galleotti R, Menegatti E, Weinstock-Guttman B, Schirda C, Magnano C, Malagoni AM, Kennedy C, Bartolomei I, Salvi F, Zivadinov R: Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. Int Angiol 2010, 29: 127–139.PubMed
3.
go back to reference Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, Mascoli F, Salvi F: A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009, 50: 1348–1358. 10.1016/j.jvs.2009.07.096PubMedCrossRef Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, Mascoli F, Salvi F: A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009, 50: 1348–1358. 10.1016/j.jvs.2009.07.096PubMedCrossRef
4.
go back to reference Zamboni P, Galeotti R: The chronic cerebrospinal venous insufficiency syndrome. Phlebology 2010, 25: 269–279. 10.1258/phleb.2010.009083PubMedCrossRef Zamboni P, Galeotti R: The chronic cerebrospinal venous insufficiency syndrome. Phlebology 2010, 25: 269–279. 10.1258/phleb.2010.009083PubMedCrossRef
5.
go back to reference Zamboni P, Menegatti E, Bartolomei I, Galeotti R, Malagoni AM, Tacconi G, Salvi F: Intracranial venous haemodynamics in multiple sclerosis. Curr Neurovasc Res 2007, 4: 252–258. 10.2174/156720207782446298PubMedCrossRef Zamboni P, Menegatti E, Bartolomei I, Galeotti R, Malagoni AM, Tacconi G, Salvi F: Intracranial venous haemodynamics in multiple sclerosis. Curr Neurovasc Res 2007, 4: 252–258. 10.2174/156720207782446298PubMedCrossRef
6.
go back to reference Zamboni P, Menegatti E, Galeotti R, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F: The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci 2009, 282: 21–27. 10.1016/j.jns.2008.11.027PubMedCrossRef Zamboni P, Menegatti E, Galeotti R, Malagoni AM, Tacconi G, Dall'Ara S, Bartolomei I, Salvi F: The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci 2009, 282: 21–27. 10.1016/j.jns.2008.11.027PubMedCrossRef
7.
go back to reference Putnam TJ: Lesions of 'encephalomyelitis' and multiple sclerosis. Venous thrombosis as the primary alteration. JAMA 1937, 1477. Putnam TJ: Lesions of 'encephalomyelitis' and multiple sclerosis. Venous thrombosis as the primary alteration. JAMA 1937, 1477.
8.
go back to reference Singh AV, Zamboni P: Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab 2009, 29: 1867–1878. 10.1038/jcbfm.2009.180PubMedCrossRef Singh AV, Zamboni P: Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab 2009, 29: 1867–1878. 10.1038/jcbfm.2009.180PubMedCrossRef
9.
go back to reference Zamboni P: The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 2006, 99: 589–593. 10.1258/jrsm.99.11.589PubMedCentralPubMedCrossRef Zamboni P: The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 2006, 99: 589–593. 10.1258/jrsm.99.11.589PubMedCentralPubMedCrossRef
10.
go back to reference Simka M, Kostecki J, Zaniewski M, Majewski E, Hartel M: Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. Int Angiol 2010, 29: 109–114.PubMed Simka M, Kostecki J, Zaniewski M, Majewski E, Hartel M: Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. Int Angiol 2010, 29: 109–114.PubMed
11.
go back to reference Al-Omari MH, Rousan LA: Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis. Int Angiol 2010, 29: 115–120.PubMed Al-Omari MH, Rousan LA: Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis. Int Angiol 2010, 29: 115–120.PubMed
12.
go back to reference Baracchini C, Perini P, Calabrese M, Causin F, Rinaldi F, Gallo P: No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol 2011, 69: 90–99. 10.1002/ana.22228PubMedCrossRef Baracchini C, Perini P, Calabrese M, Causin F, Rinaldi F, Gallo P: No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol 2011, 69: 90–99. 10.1002/ana.22228PubMedCrossRef
13.
go back to reference Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ: No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 2010, 68: 173–183.PubMedCrossRef Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ: No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 2010, 68: 173–183.PubMedCrossRef
14.
go back to reference Mayer CA, Pfeilschifter W, Lorenz MW, Nedelmann M, Bechmann I, Steinmetz H, Ziemann U: The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry 2011, 82: 436–440. 10.1136/jnnp.2010.231613PubMedCentralPubMedCrossRef Mayer CA, Pfeilschifter W, Lorenz MW, Nedelmann M, Bechmann I, Steinmetz H, Ziemann U: The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry 2011, 82: 436–440. 10.1136/jnnp.2010.231613PubMedCentralPubMedCrossRef
15.
go back to reference Zivadinov R, Marr K, Cutter G, Ramanathan M, Benedict RH, Kennedy C, Elfadil M, Yeh AE, Reuther J, Brooks C, Hunt K, Andrews M, Carl E, Dwyer MG, Hojnacki D, Weinstock-Guttman B: Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology 2011. Zivadinov R, Marr K, Cutter G, Ramanathan M, Benedict RH, Kennedy C, Elfadil M, Yeh AE, Reuther J, Brooks C, Hunt K, Andrews M, Carl E, Dwyer MG, Hojnacki D, Weinstock-Guttman B: Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology 2011.
16.
go back to reference Meyer-Schwickerath R, Haug C, Hacker A, Fink F, Seidel D, Hartung HP, Haupts MR: Intracranial venous pressure is normal in patients with multiple sclerosis. Mult Scler 2011. Meyer-Schwickerath R, Haug C, Hacker A, Fink F, Seidel D, Hartung HP, Haupts MR: Intracranial venous pressure is normal in patients with multiple sclerosis. Mult Scler 2011.
17.
go back to reference Worthington V, Killestein J, Eikelenboom MJ, Teunissen CE, Barkhof F, Polman CH, Uitdehaag BM, Petzold A: Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology 2010, 75: 1617–1622. 10.1212/WNL.0b013e3181fb449ePubMedCrossRef Worthington V, Killestein J, Eikelenboom MJ, Teunissen CE, Barkhof F, Polman CH, Uitdehaag BM, Petzold A: Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology 2010, 75: 1617–1622. 10.1212/WNL.0b013e3181fb449ePubMedCrossRef
18.
go back to reference Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J: Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol 2010, 68: 255–259. 10.1002/ana.22132PubMedCrossRef Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J: Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol 2010, 68: 255–259. 10.1002/ana.22132PubMedCrossRef
19.
go back to reference Wattjes MP, van Oosten BW, de Graaf WL, Seewann A, Bot JC, van den BR, Uitdehaag BM, Polman CH, Barkhof F: No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry 2011, 82: 429–435. 10.1136/jnnp.2010.223479PubMedCrossRef Wattjes MP, van Oosten BW, de Graaf WL, Seewann A, Bot JC, van den BR, Uitdehaag BM, Polman CH, Barkhof F: No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry 2011, 82: 429–435. 10.1136/jnnp.2010.223479PubMedCrossRef
20.
go back to reference Zivadinov R, Galeotti R, Hojnacki D, Menegatti E, Dwyer MG, Schirda C, Malagoni AM, Marr K, Kennedy C, Bartolomei I, Magnano C, Salvi F, Weinstock-Guttman B, Zamboni P: Value of MR Venography for Detection of Internal Jugular Vein Anomalies in Multiple Sclerosis: A Pilot Longitudinal Study. AJNR 2011. Zivadinov R, Galeotti R, Hojnacki D, Menegatti E, Dwyer MG, Schirda C, Malagoni AM, Marr K, Kennedy C, Bartolomei I, Magnano C, Salvi F, Weinstock-Guttman B, Zamboni P: Value of MR Venography for Detection of Internal Jugular Vein Anomalies in Multiple Sclerosis: A Pilot Longitudinal Study. AJNR 2011.
21.
go back to reference Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, Schirda CV, Magnano CR, Dolic K, Kennedy CL, Brooks CL, Reuther JA, Hunt K, Andrews M, Dwyer MG, Hojnacki DW: Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology 2011, 258: 562–570. 10.1148/radiol.10101387PubMedCrossRef Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, Schirda CV, Magnano CR, Dolic K, Kennedy CL, Brooks CL, Reuther JA, Hunt K, Andrews M, Dwyer MG, Hojnacki DW: Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology 2011, 258: 562–570. 10.1148/radiol.10101387PubMedCrossRef
22.
go back to reference Yamout B, Herlopian A, Issa Z, Habib RH, Fawaz A, Salame J, Wadih A, Awdeh H, Muallem N, Raad R, Al-Kutoubi A: Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Mult Scler 2010, 16: 1341–1348. 10.1177/1352458510385268PubMedCrossRef Yamout B, Herlopian A, Issa Z, Habib RH, Fawaz A, Salame J, Wadih A, Awdeh H, Muallem N, Raad R, Al-Kutoubi A: Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Mult Scler 2010, 16: 1341–1348. 10.1177/1352458510385268PubMedCrossRef
23.
go back to reference Ludyga T, Kazibudzki M, Simka M, Hartel M, Swierad M, Piegza J, Latacz P, Sedlak L, Tochowicz M: Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology 2010, 25: 286–295. 10.1258/phleb.2010.010053PubMedCrossRef Ludyga T, Kazibudzki M, Simka M, Hartel M, Swierad M, Piegza J, Latacz P, Sedlak L, Tochowicz M: Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology 2010, 25: 286–295. 10.1258/phleb.2010.010053PubMedCrossRef
24.
go back to reference Samson K: Experimental multiple sclerosis vascular shunting procedure halted at Stanford. Ann Neurol 2010, 67: A13-A15.CrossRef Samson K: Experimental multiple sclerosis vascular shunting procedure halted at Stanford. Ann Neurol 2010, 67: A13-A15.CrossRef
25.
go back to reference Reekers JA, Lee MJ, Belli AM, Barkhof F: Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol 2011, 34: 1–2.PubMedCentralPubMedCrossRef Reekers JA, Lee MJ, Belli AM, Barkhof F: Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol 2011, 34: 1–2.PubMedCentralPubMedCrossRef
26.
go back to reference Dawson JW: The history of disseminated sclerosis. Trans R Soc Edin 1916, 108: 397–399. Dawson JW: The history of disseminated sclerosis. Trans R Soc Edin 1916, 108: 397–399.
27.
go back to reference Adams CW: Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988, 51: 260–265. 10.1136/jnnp.51.2.260PubMedCentralPubMedCrossRef Adams CW: Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988, 51: 260–265. 10.1136/jnnp.51.2.260PubMedCentralPubMedCrossRef
28.
go back to reference MacKenzie EL, Iwasaki K, Tsuji Y: Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 2008, 10: 997–1030. 10.1089/ars.2007.1893PubMedCentralPubMedCrossRef MacKenzie EL, Iwasaki K, Tsuji Y: Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 2008, 10: 997–1030. 10.1089/ars.2007.1893PubMedCentralPubMedCrossRef
29.
go back to reference Papanikolaou G, Pantopoulos K: Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005, 202: 199–211. 10.1016/j.taap.2004.06.021PubMedCrossRef Papanikolaou G, Pantopoulos K: Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005, 202: 199–211. 10.1016/j.taap.2004.06.021PubMedCrossRef
30.
go back to reference Izawa T, Yamate J, Franklin RJ, Kuwamura M: Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Brain Res 2010, 1349: 105–114.PubMedCrossRef Izawa T, Yamate J, Franklin RJ, Kuwamura M: Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Brain Res 2010, 1349: 105–114.PubMedCrossRef
31.
go back to reference Chou SM: Acute haemorrhagic leuencephalitis as vasculinomyelopathy. J Neuropathol Exp Neurol 1982, 42: 357–365.CrossRef Chou SM: Acute haemorrhagic leuencephalitis as vasculinomyelopathy. J Neuropathol Exp Neurol 1982, 42: 357–365.CrossRef
32.
go back to reference Forge JK, Pedchenko TV, LeVine SM: Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 1998, 63: 2271–2284. 10.1016/S0024-3205(98)00512-8PubMedCrossRef Forge JK, Pedchenko TV, LeVine SM: Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 1998, 63: 2271–2284. 10.1016/S0024-3205(98)00512-8PubMedCrossRef
33.
go back to reference Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I: Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982, 106: 397–399.PubMed Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I: Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982, 106: 397–399.PubMed
34.
go back to reference Walton JC, Kaufmann JC: Iron deposits and multiple sclerosis. Arch Pathol Lab Med 1984, 108: 755–756.PubMed Walton JC, Kaufmann JC: Iron deposits and multiple sclerosis. Arch Pathol Lab Med 1984, 108: 755–756.PubMed
35.
go back to reference Nguyen-Legros J, Bizot J, Bolesse M, Pulicani JP: ["Diaminobenzidine black" as a new histochemical demonstration of exogenous iron (author's transl). Histochemistry 1980, 66: 239–244. 10.1007/BF00495737PubMedCrossRef Nguyen-Legros J, Bizot J, Bolesse M, Pulicani JP: ["Diaminobenzidine black" as a new histochemical demonstration of exogenous iron (author's transl). Histochemistry 1980, 66: 239–244. 10.1007/BF00495737PubMedCrossRef
36.
go back to reference Erb GL, Osterbur DL, LeVine SM: The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. Brain Res Dev Brain Res 1996, 93: 120–128.PubMedCrossRef Erb GL, Osterbur DL, LeVine SM: The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. Brain Res Dev Brain Res 1996, 93: 120–128.PubMedCrossRef
37.
go back to reference LeVine SM: Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J Neurosci Res 1991, 29: 413–419. 10.1002/jnr.490290317PubMedCrossRef LeVine SM: Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J Neurosci Res 1991, 29: 413–419. 10.1002/jnr.490290317PubMedCrossRef
38.
go back to reference LeVine SM, Torres MV: Morphological features of degenerating oligodendrocytes in twitcher mice. Brain Res 1992, 587: 348–352. 10.1016/0006-8993(92)91018-APubMedCrossRef LeVine SM, Torres MV: Morphological features of degenerating oligodendrocytes in twitcher mice. Brain Res 1992, 587: 348–352. 10.1016/0006-8993(92)91018-APubMedCrossRef
39.
go back to reference Drayer BP, Burger P, Hurwitz B, Dawson D, Cain J, Leong J, Herfkens R, Johnson GA: Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen. Ann Neurol 1987, 22: 546–550. 10.1002/ana.410220418PubMedCrossRef Drayer BP, Burger P, Hurwitz B, Dawson D, Cain J, Leong J, Herfkens R, Johnson GA: Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen. Ann Neurol 1987, 22: 546–550. 10.1002/ana.410220418PubMedCrossRef
40.
go back to reference Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L: T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002, 59: 62–68. 10.1001/archneur.59.1.62PubMedCrossRef Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L: T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002, 59: 62–68. 10.1001/archneur.59.1.62PubMedCrossRef
41.
go back to reference Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L: Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001, 185: 19–26. 10.1016/S0022-510X(01)00477-4PubMedCrossRef Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L: Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001, 185: 19–26. 10.1016/S0022-510X(01)00477-4PubMedCrossRef
42.
go back to reference Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR: Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med 2008, 60: 1155–1168. 10.1002/mrm.21754PubMedCrossRef Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR: Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med 2008, 60: 1155–1168. 10.1002/mrm.21754PubMedCrossRef
43.
go back to reference Rauscher A, Sedlacik J, Barth M, Haacke EM, Reichenbach JR: Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn Reson Med 2005, 54: 87–95. 10.1002/mrm.20520PubMedCrossRef Rauscher A, Sedlacik J, Barth M, Haacke EM, Reichenbach JR: Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn Reson Med 2005, 54: 87–95. 10.1002/mrm.20520PubMedCrossRef
44.
go back to reference Rauscher A, Sedlacik J, Deistung A, Mentzel HJ, Reichenbach JR: Susceptibility weighted imaging: data acquisition, image reconstruction and clinical applications. Z Med Phys 2006, 16: 240–250.PubMedCrossRef Rauscher A, Sedlacik J, Deistung A, Mentzel HJ, Reichenbach JR: Susceptibility weighted imaging: data acquisition, image reconstruction and clinical applications. Z Med Phys 2006, 16: 240–250.PubMedCrossRef
45.
go back to reference Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N: Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med 2005, 109: 155–197.PubMed Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N: Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med 2005, 109: 155–197.PubMed
46.
go back to reference Juurlink BH: The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infiltration are readily upregulated? Med Hypotheses 1998, 51: 299–303. 10.1016/S0306-9877(98)90052-4PubMedCrossRef Juurlink BH: The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infiltration are readily upregulated? Med Hypotheses 1998, 51: 299–303. 10.1016/S0306-9877(98)90052-4PubMedCrossRef
47.
go back to reference Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI: Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004, 231: 645–652. 10.1148/radiol.2313030996PubMedCrossRef Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI: Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004, 231: 645–652. 10.1148/radiol.2313030996PubMedCrossRef
48.
go back to reference Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI, Inglese M: Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006, 33: 1029–1035. 10.1016/j.neuroimage.2006.08.008PubMedCentralPubMedCrossRef Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI, Inglese M: Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006, 33: 1029–1035. 10.1016/j.neuroimage.2006.08.008PubMedCentralPubMedCrossRef
49.
go back to reference Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI: Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR 2005, 26: 1539–1547.PubMed Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI: Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR 2005, 26: 1539–1547.PubMed
50.
go back to reference Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M: White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 2009, 282: 28–33. 10.1016/j.jns.2008.12.036PubMedCentralPubMedCrossRef Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M: White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 2009, 282: 28–33. 10.1016/j.jns.2008.12.036PubMedCentralPubMedCrossRef
51.
go back to reference Aboul-Enein F, Lassmann H: Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol 2005, 109: 49–55. 10.1007/s00401-004-0954-8PubMedCrossRef Aboul-Enein F, Lassmann H: Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol 2005, 109: 49–55. 10.1007/s00401-004-0954-8PubMedCrossRef
52.
go back to reference Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD: The codependence of angiogenesis and chronic inflammation. FASEB J 1997, 11: 457–465.PubMed Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD: The codependence of angiogenesis and chronic inflammation. FASEB J 1997, 11: 457–465.PubMed
53.
go back to reference Melillo G: Hypoxia: jump-starting inflammation. Blood 2011, 117: 2561–2562. 10.1182/blood-2010-12-324913PubMedCrossRef Melillo G: Hypoxia: jump-starting inflammation. Blood 2011, 117: 2561–2562. 10.1182/blood-2010-12-324913PubMedCrossRef
54.
go back to reference Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR: VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 2009, 106: 1977–1982. 10.1073/pnas.0808698106PubMedCentralPubMedCrossRef Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR: VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 2009, 106: 1977–1982. 10.1073/pnas.0808698106PubMedCentralPubMedCrossRef
55.
go back to reference Cho ML, Jung YO, Moon YM, Min SY, Yoon CH, Lee SH, Park SH, Cho CS, Jue DM, Kim HY: Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett 2006, 103: 159–166. 10.1016/j.imlet.2005.10.020PubMedCrossRef Cho ML, Jung YO, Moon YM, Min SY, Yoon CH, Lee SH, Park SH, Cho CS, Jue DM, Kim HY: Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett 2006, 103: 159–166. 10.1016/j.imlet.2005.10.020PubMedCrossRef
56.
go back to reference Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W: Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 2000, 79: 850–857. 10.1078/0171-9335-00113PubMedCrossRef Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W: Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 2000, 79: 850–857. 10.1078/0171-9335-00113PubMedCrossRef
57.
go back to reference Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Muller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van RN, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009, 15: 545–552. 10.1038/nm.1960PubMedCrossRef Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Muller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van RN, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009, 15: 545–552. 10.1038/nm.1960PubMedCrossRef
58.
go back to reference Schweighofer B, Testori J, Sturtzel C, Sattler S, Mayer H, Wagner O, Bilban M, Hofer E: The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 2009, 102: 544–554.PubMedCentralPubMed Schweighofer B, Testori J, Sturtzel C, Sattler S, Mayer H, Wagner O, Bilban M, Hofer E: The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 2009, 102: 544–554.PubMedCentralPubMed
59.
go back to reference Fukushima K, Miyamoto S, Tsukimori K, Kobayashi H, Seki H, Takeda S, Kensuke E, Ohtani K, Shibuya M, Nakano H: Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line. Biol Reprod 2005, 73: 172–179. 10.1095/biolreprod.104.039479PubMedCrossRef Fukushima K, Miyamoto S, Tsukimori K, Kobayashi H, Seki H, Takeda S, Kensuke E, Ohtani K, Shibuya M, Nakano H: Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line. Biol Reprod 2005, 73: 172–179. 10.1095/biolreprod.104.039479PubMedCrossRef
60.
go back to reference Carvalho JF, Blank M, Shoenfeld Y: Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol 2007, 27: 246–256. 10.1007/s10875-007-9083-1PubMedCrossRef Carvalho JF, Blank M, Shoenfeld Y: Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol 2007, 27: 246–256. 10.1007/s10875-007-9083-1PubMedCrossRef
61.
go back to reference Su JJ, Osoegawa M, Matsuoka T, Minohara M, Tanaka M, Ishizu T, Mihara F, Taniwaki T, Kira J: Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 2006, 243: 21–30. 10.1016/j.jns.2005.11.006PubMedCrossRef Su JJ, Osoegawa M, Matsuoka T, Minohara M, Tanaka M, Ishizu T, Mihara F, Taniwaki T, Kira J: Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 2006, 243: 21–30. 10.1016/j.jns.2005.11.006PubMedCrossRef
62.
go back to reference Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ: Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 2002, 61: 914–925.PubMed Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ: Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 2002, 61: 914–925.PubMed
63.
go back to reference Kirk SL, Karlik SJ: VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 2003, 21: 353–363. 10.1016/S0896-8411(03)00139-2PubMedCrossRef Kirk SL, Karlik SJ: VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 2003, 21: 353–363. 10.1016/S0896-8411(03)00139-2PubMedCrossRef
64.
go back to reference Roscoe WA, Welsh ME, Carter DE, Karlik SJ: VEGF and angiogenesis in acute and chronic MOG (35–55) peptide induced EAE. J Neuroimmunol 2009, 209: 6–15. 10.1016/j.jneuroim.2009.01.009PubMedCrossRef Roscoe WA, Welsh ME, Carter DE, Karlik SJ: VEGF and angiogenesis in acute and chronic MOG (35–55) peptide induced EAE. J Neuroimmunol 2009, 209: 6–15. 10.1016/j.jneuroim.2009.01.009PubMedCrossRef
65.
go back to reference Sasaki M, Lankford KL, Brown RJ, Ruddle NH, Kocsis JD: Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor. Glia 2010, 58: 1523–1531. 10.1002/glia.21026PubMedCrossRef Sasaki M, Lankford KL, Brown RJ, Ruddle NH, Kocsis JD: Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor. Glia 2010, 58: 1523–1531. 10.1002/glia.21026PubMedCrossRef
66.
go back to reference Seabrook TJ, Littlewood-Evans A, Brinkmann V, Pollinger B, Schnell C, Hiestand PC: Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J Neuroinflammation 2010, 7: 95–105. 10.1186/1742-2094-7-95PubMedCentralPubMedCrossRef Seabrook TJ, Littlewood-Evans A, Brinkmann V, Pollinger B, Schnell C, Hiestand PC: Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J Neuroinflammation 2010, 7: 95–105. 10.1186/1742-2094-7-95PubMedCentralPubMedCrossRef
67.
go back to reference Tham E, Gielen AW, Khademi M, Martin C, Piehl F: Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand J Immunol 2006, 64: 609–622. 10.1111/j.1365-3083.2006.01851.xPubMedCrossRef Tham E, Gielen AW, Khademi M, Martin C, Piehl F: Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand J Immunol 2006, 64: 609–622. 10.1111/j.1365-3083.2006.01851.xPubMedCrossRef
69.
go back to reference Halin C, Fahrngruber H, Meingassner JG, Bold G, Littlewood-Evans A, Stuetz A, Detmar M: Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. Am J Pathol 2008, 173: 265–277. 10.2353/ajpath.2008.071074PubMedCentralPubMedCrossRef Halin C, Fahrngruber H, Meingassner JG, Bold G, Littlewood-Evans A, Stuetz A, Detmar M: Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. Am J Pathol 2008, 173: 265–277. 10.2353/ajpath.2008.071074PubMedCentralPubMedCrossRef
70.
go back to reference Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF: Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci USA 2009, 106: 21264–21269. 10.1073/pnas.0907550106PubMedCentralPubMedCrossRef Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF: Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci USA 2009, 106: 21264–21269. 10.1073/pnas.0907550106PubMedCentralPubMedCrossRef
71.
go back to reference Miotla J, Maciewicz R, Kendrew J, Feldmann M, Paleolog E: Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000, 80: 1195–1205. 10.1038/labinvest.3780127PubMedCrossRef Miotla J, Maciewicz R, Kendrew J, Feldmann M, Paleolog E: Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000, 80: 1195–1205. 10.1038/labinvest.3780127PubMedCrossRef
72.
go back to reference Gimbrone MA Jr, Alexander RW: Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 1975, 189: 219–220. 10.1126/science.1138377PubMedCrossRef Gimbrone MA Jr, Alexander RW: Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 1975, 189: 219–220. 10.1126/science.1138377PubMedCrossRef
73.
go back to reference Schlondorff D, Perez J, Satriano JA: Differential stimulation of PGE2 synthesis in mesangial cells by angiotensin and A23187. Am J Physiol 1985, 248: C119-C126.PubMed Schlondorff D, Perez J, Satriano JA: Differential stimulation of PGE2 synthesis in mesangial cells by angiotensin and A23187. Am J Physiol 1985, 248: C119-C126.PubMed
74.
go back to reference Williams B, Baker AQ, Gallacher B, Lodwick D: Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995, 25: 913–917.PubMedCrossRef Williams B, Baker AQ, Gallacher B, Lodwick D: Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995, 25: 913–917.PubMedCrossRef
75.
go back to reference Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, Ferri C, Desideri G, Gulino A, Santucci A: Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999, 100: 1646–1652.PubMedCrossRef Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, Ferri C, Desideri G, Gulino A, Santucci A: Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999, 100: 1646–1652.PubMedCrossRef
76.
go back to reference Tayeh MA, Scicli AG: Angiotensin II and bradykinin regulate the expression of P-selectin on the surface of endothelial cells in culture. Proc Assoc Am Physicians 1998, 110: 412–421.PubMed Tayeh MA, Scicli AG: Angiotensin II and bradykinin regulate the expression of P-selectin on the surface of endothelial cells in culture. Proc Assoc Am Physicians 1998, 110: 412–421.PubMed
77.
go back to reference Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998, 83: 952–959.PubMedCrossRef Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998, 83: 952–959.PubMedCrossRef
78.
go back to reference Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998, 161: 430–439.PubMed Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998, 161: 430–439.PubMed
79.
go back to reference Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RA: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997, 100: 1047–1058. 10.1172/JCI119615PubMedCentralPubMedCrossRef Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RA: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997, 100: 1047–1058. 10.1172/JCI119615PubMedCentralPubMedCrossRef
80.
go back to reference Gomez RA, Norling LL, Wilfong N, Isakson P, Lynch KR, Hock R, Quesenberry P: Leukocytes synthesize angiotensinogen. Hypertension 1993, 21: 470–475.PubMedCrossRef Gomez RA, Norling LL, Wilfong N, Isakson P, Lynch KR, Hock R, Quesenberry P: Leukocytes synthesize angiotensinogen. Hypertension 1993, 21: 470–475.PubMedCrossRef
81.
go back to reference Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, Abdi R: Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 2007, 18: 1093–1102. 10.1681/ASN.2006070707PubMedCrossRef Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, Abdi R: Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 2007, 18: 1093–1102. 10.1681/ASN.2006070707PubMedCrossRef
82.
go back to reference Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007, 204: 2449–2460. 10.1084/jem.20070657PubMedCentralPubMedCrossRef Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007, 204: 2449–2460. 10.1084/jem.20070657PubMedCentralPubMedCrossRef
83.
go back to reference Pool JL: The role of angiotensin II in hypertension and end-organ damage. Int J Clin Pract Suppl 2000, 4–8. Pool JL: The role of angiotensin II in hypertension and end-organ damage. Int J Clin Pract Suppl 2000, 4–8.
84.
go back to reference Matsushita T, Isobe N, Kawajiri M, Mogi M, Tsukuda K, Horiuchi M, Ohyagi Y, Kira J: CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity. J Neurol Sci 2010, 295: 41–45. 10.1016/j.jns.2010.05.014PubMedCrossRef Matsushita T, Isobe N, Kawajiri M, Mogi M, Tsukuda K, Horiuchi M, Ohyagi Y, Kira J: CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity. J Neurol Sci 2010, 295: 41–45. 10.1016/j.jns.2010.05.014PubMedCrossRef
85.
go back to reference Constantinescu CS, Goodman DB, Grossman RI, Mannon LJ, Cohen JA: Serum angiotensin-converting enzyme in multiple sclerosis. Arch Neurol 1997, 54: 1012–1015.PubMedCrossRef Constantinescu CS, Goodman DB, Grossman RI, Mannon LJ, Cohen JA: Serum angiotensin-converting enzyme in multiple sclerosis. Arch Neurol 1997, 54: 1012–1015.PubMedCrossRef
86.
go back to reference Platten M, Youssef S, Hur EM, Ho PP, Han MH, Lanz TV, Phillips LK, Goldstein MJ, Bhat R, Raine CS, Sobel RA, Steinman L: Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 2009, 106: 14948–14953. 10.1073/pnas.0903958106PubMedCentralPubMedCrossRef Platten M, Youssef S, Hur EM, Ho PP, Han MH, Lanz TV, Phillips LK, Goldstein MJ, Bhat R, Raine CS, Sobel RA, Steinman L: Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 2009, 106: 14948–14953. 10.1073/pnas.0903958106PubMedCentralPubMedCrossRef
87.
go back to reference Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, Gaupp S, Rump LC, Gold R, Linker RA: Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA 2009, 106: 14942–14947. 10.1073/pnas.0903602106PubMedCentralPubMedCrossRef Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, Gaupp S, Rump LC, Gold R, Linker RA: Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA 2009, 106: 14942–14947. 10.1073/pnas.0903602106PubMedCentralPubMedCrossRef
Metadata
Title
Vascular pathology in multiple sclerosis: mind boosting or myth busting?
Authors
Anne Waschbisch
Arndt Manzel
Ralf A Linker
De-Hyung Lee
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Experimental & Translational Stroke Medicine / Issue 1/2011
Electronic ISSN: 2040-7378
DOI
https://doi.org/10.1186/2040-7378-3-7

Other articles of this Issue 1/2011

Experimental & Translational Stroke Medicine 1/2011 Go to the issue